Trial intelligence / Profile preview

Dexmedetomidine ED50 for Emergence Agitation in Children

NCT01374737Phase 4Unknown

Sponsor
Seoul National University Hospital
Start
Jun 2011
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of dexmedetomidine in Emergence agitation (EA), sponsored by Seoul National University Hospital. Primary endpoint: Emergence Agitation at 30 minutes. Status: unknown.

02

Drugs

dexmedetomidine
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on NCT01374737.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01374737.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call